Cost-effectiveness of injectable opioid treatment versus oral methadone for chronic heroin addiction
4 November 2013
Injectable opioid treatments are more cost-effective than optimised oral methadone for chronic refractory heroin addiction. The choice between supervised injectable heroin and injectable methadone is less clear. There is currently evidence to suggest superior effectiveness of injectable heroin but at a cost that policy makers may find unacceptable. Future research should consider the use of decision analytic techniques to model expected costs and benefits of the treatments over the longer term.
Click here to read the full publication (restricted access)
Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.